
VTGN
USDVistagen Therapeutics Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$4.180
Kõrge
$4.296
Madal
$4.060
Maht
0.21M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
124.9M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
0.57M
Börs
NCM
Valuuta
USD
52 nädala vahemik
Seotud uudised
Vistagen to Report Fiscal Year 2026 Second Quarter Results and Host Corporate Update Conference Call on November 13, 2025
Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called
Vistagen Completes PALISADE-3 Phase 3 Public Speaking Challenge Study for the Acute Treatment of Social Anxiety Disorder
Topline results for the trial are expected by year end Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a
Seotud aktsiad
ONTF
ON24 Inc.
CSWCZ
Capital Southwest Corporation 7.75% Notes due 2028
DLPN
Dolphin Entertainment Inc.
BXMX
Nuveen S&P 500 Buy-Write Income Fund Common Shares of Beneficial Interest
CMAXW
CareMax Inc. Warrant
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.